Autori: Bila Jelena S
Naslov | VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG) (Article) |
Autori | Kastritis Efstathios ... ![]() ![]() ![]() |
Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2025), vol. 25 br. 2, str. E71-E81 |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges (Review) |
Autori | Kozarac Sofija Ivanovic Jelena Mitrovic Marko Tomic-Vujovic Kristina ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | FRONTIERS IN PHARMACOLOGY, (2025), vol. 15 br. , str. - |
Projekat | Ministry of Science, Technological Development and Innovation [451-03-65/2024-03/200110] |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Risk Factors for Venous Thromboembolism in Acute Promyelocytic Leukemia (Article) |
Autori | Sabljic Nikica ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | CANCERS, (2024), vol. 16 br. 24, str. - |
Projekat | Ministry of Science, Technological Development and Innovation of the Republic of Serbia; [451-03-65/2004-03/200110] |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Does Double Mean Trouble? Coexistence of Myeloproliferative and Lymphoproliferative Neoplasms (Article) |
Autori | Lekovic Danijela R ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Info | JOURNAL OF CLINICAL MEDICINE, (2024), vol. 13 br. 6, str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study (Article) |
Autori | Pour Ludek ... Bila Jelena S ![]() |
Info | HAEMATOLOGICA, (2024), vol. 109 br. 3, str. 895-905 |
Projekat | [NCT04649060] |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Bortezomib-Cyclophosphamide-Dexamethasone (VCD) Vs Bortezomib-LenalidomideDexamethasone (VRD) in Newly Diagnosed Multiple Myeloma: A Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG) (Meeting Abstract) |
Autori | Kastritis Efstathios ... Bila Jelena S ![]() ![]() |
Info | BLOOD, (2023), vol. 142 br. , Suppl. 1, str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3trial (Article) |
Autori | Dimopoulos Meletios Athanasios ... Bila Jelena S ![]() |
Info | LANCET HAEMATOLOGY, (2023), vol. 10 br. 10, str. E813-E824 |
Projekat | European Myeloma Network; Janssen Research Development |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy (Meeting Abstract) |
Autori | Mateos Maria-Victoria Szarejko Monika Bila Jelena S ![]() |
Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S200-S201 |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | The second revision of international staging system (R2-ISS) in newly diagnosed multiple myeloma patients: RWE settings (Meeting Abstract) |
Autori | Sretenovic Aleksandra M Mitrovic Marko Vukosavljevic Nikola Kecman Natalija Jovanovic Jelica V Bukumiric Zoran M ![]() ![]() |
Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S93-S93 |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | MajesTEC-4: Phase 3 trial of Teclistamab plus Lenalidomide versus Lenalidomide in patients with newly diagnosed multiple myeloma (Meeting Abstract) |
Autori | Cook Gordon ... Bila Jelena S ![]() |
Info | BRITISH JOURNAL OF HAEMATOLOGY, (2023), vol. 201 br. , Suppl. 1, str. 57-57 |
Ispravka | Web of Science Elečas Rang časopisa |
|